These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23493770)

  • 1. Interaction between FXIII and fibrinogen.
    Kohler HP
    Blood; 2013 Mar; 121(11):1931-2. PubMed ID: 23493770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
    Smith KA; Pease RJ; Avery CA; Brown JM; Adamson PJ; Cooke EJ; Neergaard-Petersen S; Cordell PA; Ariëns RA; Fishwick CW; Philippou H; Grant PJ
    Blood; 2013 Mar; 121(11):2117-26. PubMed ID: 23303819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between factor XIII and the alphaC region of fibrinogen.
    Smith KA; Adamson PJ; Pease RJ; Brown JM; Balmforth AJ; Cordell PA; Ariëns RA; Philippou H; Grant PJ
    Blood; 2011 Mar; 117(12):3460-8. PubMed ID: 21224475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen.
    Krarup A; Gulla KC; Gál P; Hajela K; Sim RB
    Biochim Biophys Acta; 2008 Sep; 1784(9):1294-300. PubMed ID: 18456010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.
    Jadhav MA; Isetti G; Trumbo TA; Maurer MC
    Biochemistry; 2010 Apr; 49(13):2918-24. PubMed ID: 20218626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation.
    Trumbo TA; Maurer MC
    Biochemistry; 2002 Feb; 41(8):2859-68. PubMed ID: 11851434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage.
    Mohammed RDS; Piell KM; Maurer MC
    Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fibrinogen and Ca2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII.
    Shafer JA; Lewis SD; Janus TJ; Lorand L
    Ann N Y Acad Sci; 1986; 485():134-9. PubMed ID: 3471144
    [No Abstract]   [Full Text] [Related]  

  • 12. Leptospira Immunoglobulin-Like Protein B (LigB) Binds to Both the C-Terminal 23 Amino Acids of Fibrinogen αC Domain and Factor XIII: Insight into the Mechanism of LigB-Mediated Blockage of Fibrinogen α Chain Cross-Linking.
    Hsieh CL; Chang E; Tseng A; Ptak C; Wu LC; Su CL; McDonough SP; Lin YP; Chang YF
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004974. PubMed ID: 27622634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
    Lorand L
    Ann N Y Acad Sci; 2001; 936():291-311. PubMed ID: 11460485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII: novel structural and functional aspects.
    Komáromi I; Bagoly Z; Muszbek L
    J Thromb Haemost; 2011 Jan; 9(1):9-20. PubMed ID: 20880254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.
    Jadhav MA; Lucas RC; Goldsberry WN; Maurer MC
    Biochim Biophys Acta; 2011 Dec; 1814(12):1955-63. PubMed ID: 21798378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of plasma factor XIII to thrombin-receptor activated human platelets.
    Nagy B; Simon Z; Bagoly Z; Muszbek L; Kappelmayer J
    Thromb Haemost; 2009 Jul; 102(1):83-9. PubMed ID: 19572072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
    Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC
    Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.